By Christine Caulfield (April 23, 2008, 12:00 AM EDT) -- Drugmaker Hoffmann-La Roche Inc. lost the third of potentially hundreds of trials over its controversial Accutane on Tuesday, when a New Jersey jury awarded $10.5 million to a woman who alleged the acne treatment caused her inflammatory bowel disease.
Plaintiffs attorney Pete Kaufman said the award is the largest so far in the three cases to go to trial since May last year and should serve as a warning to the Nutley, N.J.-based pharmaceutical company to reconsider its strategy to fight the lawsuits in court.
The jury in New Jersey's Superior Court deliberated for just three hours after a three-week trial,...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!